USFDA has issued notice to the Hyderabad unit of Aurobindo Pharma and calming the nerves of the investors Surajit Pal of Prabhudas Lilladher says that it is a non-event and there is no need to worry.
first published: Dec 20, 2016 10:50 am
A collection of the most-viewed Moneycontrol videos.
Nifty Knocks At 26,000 As 4-Day Losing Streak Halts; Shriram Fin-MUFG Deal Sealed| Closing Bell Live
Nifty Eyes Rebound After 4-Day Slide; ICICI Pru AMC Makes D-Street Debut Today | Opening Bell Live
How you can invest in foreign stocks from India
6 Behavioural Biases Every Investor Must Avoid | Improve Your Investment Outcomes
